Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Clinically insignificant improvement of prostate cancer prediction by addition of sex steroid hormones and SHBG serum levels to serum PSA, fPSA%, and age in a screening settingIsabel Heidegger, Marina Popovscaia, Reinhold Ramoner, et al.
Anticancer Research|December 11, 2013
The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-upRenate Pichler, Isabel Heidegger, Nicolai Leonhartsberger, et al.
Translational Andrology and Urology|July 21, 2025
SChLAP1 regulates the metastasis and apoptosis of prostate cancer partly via miR-101Xuanming Huang, Shengye Chen, Chengwei Wu, et al.
World Journal of Urology|October 26, 2022
Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment responseMona Kafka, Thomas Burtscher, Josef Fritz, et al.
BJU International|September 24, 2017
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillanceRenate Pichler, Josef Fritz, Gennadi Tulchiner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 22, 2014
Long-term follow up of renal anastomosing hemangioma mimicking renal angiosarcomaIsabel Heidegger, Renate Pichler, Georg Schäfer, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Oncotarget|October 6, 2017
PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyRenate Pichler, Isabel Heidegger, Josef Fritz, et al.
Plos One|February 7, 2015
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceIsabel Heidegger, Viktor Skradski, Eberhard Steiner, et al.
Urologia Internationalis|June 6, 2013
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraineRenate Pichler, Isabel Heidegger, Gerald Klinglmair, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Clinically insignificant improvement of prostate cancer prediction by addition of sex steroid hormones and SHBG serum levels to serum PSA, fPSA%, and age in a screening settingIsabel Heidegger, Marina Popovscaia, Reinhold Ramoner, et al.
Anticancer Research|December 11, 2013
The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-upRenate Pichler, Isabel Heidegger, Nicolai Leonhartsberger, et al.
Translational Andrology and Urology|July 21, 2025
SChLAP1 regulates the metastasis and apoptosis of prostate cancer partly via miR-101Xuanming Huang, Shengye Chen, Chengwei Wu, et al.
World Journal of Urology|October 26, 2022
Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment responseMona Kafka, Thomas Burtscher, Josef Fritz, et al.
BJU International|September 24, 2017
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillanceRenate Pichler, Josef Fritz, Gennadi Tulchiner, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 22, 2014
Long-term follow up of renal anastomosing hemangioma mimicking renal angiosarcomaIsabel Heidegger, Renate Pichler, Georg Schäfer, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
Oncotarget|October 6, 2017
PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyRenate Pichler, Isabel Heidegger, Josef Fritz, et al.
Plos One|February 7, 2015
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillanceIsabel Heidegger, Viktor Skradski, Eberhard Steiner, et al.
Urologia Internationalis|June 6, 2013
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraineRenate Pichler, Isabel Heidegger, Gerald Klinglmair, et al.
Pageof 16